Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas: “it’s a numbers game”—implications for WNT medulloblastoma dose-reduction clinical trials

Detalles Bibliográficos
Autor principal: Gottardo, Nicholas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807471/
https://www.ncbi.nlm.nih.gov/pubmed/36403175
http://dx.doi.org/10.1007/s00401-022-02518-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807471/
https://www.ncbi.nlm.nih.gov/pubmed/36403175
http://dx.doi.org/10.1007/s00401-022-02518-0

Ejemplares similares